[go: up one dir, main page]

US7356120B2 - Integrated quality assurance for in image guided radiation treatment delivery system - Google Patents

Integrated quality assurance for in image guided radiation treatment delivery system Download PDF

Info

Publication number
US7356120B2
US7356120B2 US11/234,708 US23470805A US7356120B2 US 7356120 B2 US7356120 B2 US 7356120B2 US 23470805 A US23470805 A US 23470805A US 7356120 B2 US7356120 B2 US 7356120B2
Authority
US
United States
Prior art keywords
marker
radiation
target
ring
shadow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US11/234,708
Other languages
English (en)
Other versions
US20070071176A1 (en
Inventor
William Main
Eric Earnst
Gopinath Kuduvalli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Accuray LLC
Original Assignee
Accuray Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accuray Inc filed Critical Accuray Inc
Priority to US11/234,708 priority Critical patent/US7356120B2/en
Assigned to ACCURAY INCORPORATED reassignment ACCURAY INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EARNST, ERIC, KUDUVALLI, GOPINATH, MAIN, WILLIAM
Priority to PCT/US2006/036620 priority patent/WO2007038123A2/fr
Publication of US20070071176A1 publication Critical patent/US20070071176A1/en
Priority to US12/070,106 priority patent/US7604405B2/en
Application granted granted Critical
Publication of US7356120B2 publication Critical patent/US7356120B2/en
Assigned to CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT reassignment CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT ASSIGNMENT FOR SECURITY - PATENTS Assignors: ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED
Assigned to ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED reassignment ACCURAY INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CERBERUS BUSINESS FINANCE, LLC. AS COLLATERAL AGENT
Assigned to MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST) reassignment MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST) SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED
Assigned to MIDCAP FINANCIAL TRUST reassignment MIDCAP FINANCIAL TRUST SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED
Assigned to MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO EXISTING ADMINISTRATIVE AGENT reassignment MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO EXISTING ADMINISTRATIVE AGENT ASSIGNMENT OF SECURITY AGREEMENTS Assignors: MIDCAP FUNDING X TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST), AS EXISTING ADMINISTRATIVE AGENT
Assigned to SILICON VALLEY BANK, AS ADMINISTRATIVE AND COLLATERAL AGENT reassignment SILICON VALLEY BANK, AS ADMINISTRATIVE AND COLLATERAL AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED
Assigned to ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED reassignment ACCURAY INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING X TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST)
Assigned to ACCURAY INCORPORATED, TOMOTHERAPY INCORPORATED reassignment ACCURAY INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FINANCIAL TRUST
Assigned to ACCURAY INCORPORATED reassignment ACCURAY INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: FIRST-CITIZENS BANK & TRUST COMPANY
Assigned to ACCURAY LLC reassignment ACCURAY LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCURAY INCORPORATED
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1075Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/58Testing, adjusting or calibrating thereof
    • A61B6/582Calibration
    • A61B6/583Calibration using calibration phantoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1049Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
    • A61N2005/1061Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using an x-ray imaging system having a separate imaging source
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1075Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
    • A61N2005/1076Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus using a dummy object placed in the radiation field, e.g. phantom

Definitions

  • This disclosure relates generally to quality assurance for image guided radiation treatment delivery systems.
  • Radiosurgery very intense and precisely collimated doses of radiation in a beam from a source outside a patient's body are delivered to a target region in the body, in order to destroy lesions.
  • the target region consists of a volume of tumorous tissue.
  • Radiosurgery requires an extremely accurate spatial localization of the targeted lesions.
  • Radiosurgery offers apparent advantages over conventional surgery, during which a surgeon's scalpel removes the lesion, by avoiding the common risks and problems associated with open surgery. These problems include invasiveness, high costs, the need for in-hospital stays and general anesthesia, and complications associated with post-operative recovery. When a lesion is located close to critical organs, nerves, or arteries, the risks of open surgery are even greater.
  • CT Computed tomography
  • MRI magnetic resonance imaging
  • other imaging modalities enable practitioners to precisely locate a lesion relative to skeletal landmarks or implanted fiducial markers.
  • radiosurgery necessitates high precision diagnosis and high precision radiation source control.
  • the consequences of deviating outside the prescribed tolerances for the diagnosis and the radiation source control can be potentially devastating to a patient.
  • quality assurance mechanisms should be integrated into a radiation treatment delivery system to ensure proper alignment and configuration of the system prior to delivering a prescribed radiation dose to a patient.
  • Conventional quality assurance mechanisms include pointing the radiation source at an alignment marker, delivering a radiation dose to the alignment marker, and then analyzing the alignment marker itself to determine if the prescribed dose was actually delivered to the correct location. If the prescribed dose was delivered as expected, then the radiation treatment delivery system is deemed properly aligned. If the prescribed dose was not delivered as expected, then the radiation treatment delivery system is deemed misaligned.
  • Conventional alignment markers include silver loaded gels capsules or photographic film canisters that can store readable information about the distribution of the radiation dose delivered to the alignment marker. However, extracting this alignment information from silver loaded gels or photographic film canisters located within the alignment marker itself is a time consuming and costly task.
  • FIG. 1 is a diagram illustrating use of a quality assurance marker to execute an alignment confidence check of an image guided radiation treatment system, in accordance with an embodiment of the invention.
  • FIG. 2A is a perspective view illustrating a quality assurance marker for housing a spherical target for alignment validation of an image guided radiation treatment system, in accordance with an embodiment of the invention.
  • FIG. 2B is a perspective view illustrating a quality assurance marker opened to allow swapping of the spherical target, in accordance with an embodiment of the invention.
  • FIG. 3A is a diagram illustrating a target shadow and a beam exposure field having concentric centroids indicating alignment of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 3B is a diagram illustrating a target shadow and a beam exposure field having non-concentric centroids indicating misalignment of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 4A is a perspective view of spherical and ring targets for use with a quality assurance marker to provide displacement and rotational validation of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 4B is a perspective view illustrating a quality assurance marker for holding spherical and ring targets for validation of an image guided radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 5A is a diagram illustrating target shadows and a beam exposure field all having concentric centroids indicating alignment of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 5B is a diagram illustrating target shadows and a beam exposure field having non-concentric centroids indicating misalignment of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 6 is a flow chart illustrating a process to provide quality assurance of alignment between an imaging guidance system, a positioning system, and a therapeutic radiation source of a radiation treatment delivery system, in accordance with an embodiment of the invention.
  • FIG. 7 is a block diagram illustrating a therapeutic patient treatment system for generating diagnostic images, generating a treatment plan, and delivering the treatment plan, in accordance with an embodiment of the invention.
  • FIG. 8 is a perspective view of a treatment delivery system, in accordance with an embodiment of the invention.
  • Embodiments of a system and method for quality assurance of an image guided radiation treatment delivery system are described herein.
  • numerous specific details are set forth to provide a thorough understanding of the embodiments.
  • One skilled in the relevant art will recognize, however, that the techniques described herein can be practiced without one or more of the specific details, or with other methods, components, materials, etc.
  • well-known structures, materials, or operations are not shown or described in detail to avoid obscuring certain aspects.
  • FIG. 1 is a diagram illustrating use of a quality assurance (“QA”) marker to execute an alignment confidence check on a radiation treatment delivery system 100 , in accordance with an embodiment of the invention.
  • the illustrated embodiment of radiation treatment delivery system 100 includes a therapeutic radiation source 105 , a treatment couch 110 , detectors 115 A and 115 B (collectively 115 , also referred to as imagers), and imaging sources 120 A and 120 B (collectively 120 ).
  • QA quality assurance
  • Radiation treatment delivery system 100 may be used to perform radiosurgery to treat or destroy lesions within a patient.
  • the patient rests on treatment couch 110 , the treatment couch is maneuvered to position the lesion or volume of interest (“VOI”) to a preset position or within an operating range accessible to therapeutic radiation source 105 (e.g., field of view).
  • VOI lesion or volume of interest
  • radiation treatment delivery system 100 is an image guided radiation treatment delivery system.
  • imaging sources 120 and detectors 115 are an imaging guidance system that provides visual control over the position of treatment couch 110 and the patient thereon.
  • treatment couch 110 may be coupled to a positioning system (e.g., robotic arm) that receives feedback from the imaging guidance system to provide accurate control over both the displacement and orientation of the VOI within the patient and therapeutic radiation source 105 .
  • a positioning system e.g., robotic arm
  • QA quality assurance
  • a QA marker 130 may be placed on treatment couch 110 to perform one of these QA mechanisms.
  • the illustrated embodiment of QA marker 130 commonly referred to as a “shadow phantom” for reasons described below, includes an alignment target 135 and fiducials 140 .
  • Fiducials 140 are used by the imaging guidance system to position QA marker 130 to a preset position.
  • therapeutic radiation source 105 is also maneuvered into a preset position. From this preset position, therapeutic radiation source 105 emits a radiation beam 150 along a predetermined trajectory passing through QA marker 130 and impinging upon one of detectors 115 (illustrated as detector 115 A).
  • a beam exposure field is produced or develops on detector 115 A outlining a shadow cast by alignment target 135 .
  • alignment of therapeutic radiation source 105 can be validated or a misalignment exposed.
  • the amount of exposure in the beam exposure field may be analyzed to determine if the correct dose was delivered.
  • QA marker 130 provides three-dimensional translational alignment validation. In one embodiment, QA marker 130 provides both three-dimensional translational alignment validation and rotational (e.g., roll, pitch, yaw) alignment validation.
  • Translational/rotational alignment validation includes validating the ability of the imaging guidance system and the positioning system to achieve accurate translational/rotational placement of QA marker 130 at the preset position and the ability of therapeutic radiation source 105 to arrive at its translational/rotational preset position.
  • the exposure image generated by propagating radiation beam 150 through QA marker 130 is captured by detectors 115 .
  • Detectors 115 may be implemented using digital imagers (e.g., PerkinElmer imager).
  • the exposure image may be captured using film 137 , such as standard (MD) radiochromic film, high-sensitivity (“HS”) radiochromic film, and the like.
  • therapeutic radiation source 105 may be aligned normal to detectors 115 /films 137 such that the exposure images (and shadows) are cast onto detectors 115 /films 137 .
  • film holder 131 is used to hold films 133 adjacent to QA marker 130 .
  • therapeutic radiation source 105 may be aligned normal to each film 133 prior to emitting radiation beam 150 . It should be appreciated that if film holder 131 and films 133 are used to capture the exposure images, then films 137 need not be present, and visa versa. Furthermore, a variety of other positions/orientations of film and/or therapeutic radiation source 105 may be used to generate and capture exposure images of QA marker 130 .
  • the intensity, duration, and collimation of the radiation beam 150 i.e., treatment dose
  • the amount of exposure on the film may be analyzed and compared to determine whether the correct dose of radiation was delivered.
  • FIG. 2A is a perspective view illustrating a QA marker 200 for supporting a spherical target to validate alignment of radiation treatment delivery system 100 , in accordance with an embodiment of the invention.
  • QA marker 200 represents one possible embodiment of QA marker 130 illustrated in FIG. 1 .
  • the illustrated embodiment of QA marker 200 includes a housing 205 having a spherical void 210 for holding a spherical target 215 and fiducials 140 . It should be appreciated that the size, shapes, and orientations of the various components of QA marker 200 are not illustrated to scale.
  • housing 205 is formed of ABS plastic. However, housing 205 may be formed of a variety of materials being transparent or translucent to radiation beam 150 . In one embodiment, housing 205 is also translucent or penetrable by the emissions of imaging sources 120 . Although housing 205 is illustrated as a cube, housing 205 may assume any convenient shape.
  • FIG. 2B is a perspective view illustrating a QA marker 200 opened to enable swapping of spherical target 215 , in accordance with an embodiment of the invention.
  • QA marker 200 may be formed of multiple separable portions (e.g., two or more). These portions may be secured with fasteners (e.g., plastic screws, bolts, pins, rivets, etc.) inserted into thru-holes 220 .
  • fasteners e.g., plastic screws, bolts, pins, rivets, etc.
  • Embodiments of QA marker 200 are separable to support multiple imaging modalities compatible with different materials for spherical target 215 .
  • a spherical target 215 formed of a radio opaque material e.g., metal, metal alloy, etc.
  • a spherical target 215 formed of acrylic may be inserted into spherical void 210 .
  • the particular material selected for spherical target 215 is dependent upon the imaging modality to provide sufficient image contrast.
  • housing 205 is approximately 2.5 inches square with a 1.25 inch diameter spherical void 210 . Other sizes, shapes, and materials are possible.
  • QA marker 200 includes three fiducials 140 embedded within housing 205 at three separate corners. Fiducials 140 are embedded within QA marker 200 to enable the imaging guidance system to track QA marker 200 .
  • fiducials 140 are gold wires approximately 1 mm in diameter and 5 mm long. However, fiducials 140 may assume a variety of shapes, sizes, orientations, and positions that are convenient to track. Although three identical fiducials 140 are illustrated, more or less, similar or individually distinct fiducials 140 may be incorporated into housing 205 for tracking purposes.
  • housing 205 does not include any fiducials 140 , but rather uses spherical target 215 itself for image tracking.
  • QA marker 200 may be exposed to one or more radiation beams 150 along one or more trajectories 230 to capture exposure images of QA marker 200 for validating system alignment.
  • trajectories 230 may vary for various different embodiments.
  • trajectories 230 may include trajectories that are horizontal, vertical, normal to any of the sides of housing 205 , or otherwise.
  • These exposure images may be captured with therapeutic radiation source 105 having a variety of different separation distances from the center of alignment target 135 (referred to as source to axis distance “SAD”).
  • SAD source to axis distance
  • the SAD may be equal to 650 mm, 800 mm, 950 mm, or otherwise.
  • FIGS. 3A and 3B illustrate two possible exposure images 300 A and 300 B of QA marker 200 .
  • FIG. 3A is a diagram illustrating a center shadow 305 and a beam exposure field 310 having concentric centroids.
  • the presence of concentrically aligned centroids in exposure image 300 A indicates that radiation treatment delivery system 100 is properly aligned and calibrated (at least for the degrees of freedom tested by the particular image).
  • the presence of concentrically aligned centroids in exposure image 300 A is a confidence check that the imaging guidance system and the positioning system were able to accurately place QA marker 200 at the preset position and that the therapeutic radiation source 105 was able to achieve its preset position.
  • FIG. 3B is a diagram illustrating center shadow 305 and beam exposure field 310 having non-concentric centroids 315 and 320 , respectively.
  • the presence of non-concentrically aligned centroids 315 and 320 in exposure image 300 B indicates that radiation treatment delivery system 100 is misaligned.
  • the presence of non-concentrically aligned centroids 315 and 320 in exposure image 300 B indicates that either the imaging guidance system or the positioning system did not accurately place QA marker 200 at the preset position or that the therapeutic radiation source 105 did not achieve its preset position.
  • exposure images 300 A and 300 B may be captured (e.g., using a digital imager, film, etc.), imported into a software tool, and analyzed to pinpoint the centroids of center shadow 305 and beam exposure field 310 . If the centroids overlap within a margin of error, then alignment is determined. If the centroids are displaced from each other, then misalignment is determined. This automated analysis is called stereotactic alignment.
  • a software product called RIT113 by Radiological Imaging Technology, Inc. of Colorado Springs, Colo. may be used in connection with embodiments of the invention to perform stereotactic alignment analysis.
  • FIGS. 4A and 4B illustrate an alignment target 400 A for use with a QA marker 400 B to provide displacement and rotational validation of radiation treatment delivery system 100 , in accordance with an embodiment of the invention.
  • Alignment target 400 A is another possible embodiment of alignment target 135 and QA marker 400 B is another possible embodiment of QA marker 130 , illustrated in FIG. 1 .
  • the illustrated embodiment of alignment target 400 A includes a spherical target 405 , and ring targets 410 A and 410 B (collectively 410 ).
  • the illustrated embodiment of QA marker 400 B includes a housing 415 including a spherical void 420 , ring voids 425 A and 425 B (collectively 425 ), and fiducials 140 .
  • QA marker 400 B may be formed of multiple separable portions (not illustrated) enabling alignment target 400 A to be inserted/removed into/from housing 415 .
  • alignment marker 400 A may be formed of a radio opaque material (e.g., metal) for imaging by therapeutic radiation source 105 or imaging sources 120 , acrylic for CT imaging, or otherwise.
  • housing 415 is formed of ABS plastic or other materials being transparent or translucent to the various imaging modalities.
  • ring target 410 A is supported within ring void 425 A
  • ring target 410 B is supported within ring void 425 B
  • spherical target 405 is supported within spherical void 420 .
  • ring targets 410 are orientated such that ring axes 430 are substantially aligned with a trajectory passing through the center of spherical target 405 .
  • Ring centers 435 have an inside diameter that is larger than a diameter of spherical target 405 .
  • FIGS. 5A and 5B illustrate two possible exposure images 500 A and 500 B of QA marker 400 B.
  • FIG. 5A is a diagram illustrating a center shadow 505 , a ring shadow 507 , and a beam exposure field 510 having concentric centroids.
  • the presence of concentrically aligned centroids in exposure image 500 A indicates that radiation treatment delivery system 100 is properly aligned and calibrated.
  • exposure image 500 A is a confidence check indicating that the imaging guidance system and the positioning system were able to accurately place QA marker 400 B at the preset position and that the therapeutic radiation source 105 was able to achieve its preset position.
  • Alignment target 400 A is capable of exposing both translational displacement error and rotational error.
  • FIG. 5B is a diagram illustrating center shadow 505 , ring shadow 507 , and beam exposure field 510 having non-concentric centroids 515 , 520 , and 525 , respectively.
  • the presence of non-concentrically aligned centroids 515 , 520 , and 525 in exposure image 500 B indicates that radiation treatment delivery system 100 is misaligned.
  • the presence of non-concentrically aligned centroids 515 , 520 , and 525 in exposure image 500 B indicates that either the imaging guidance system and the positioning system did not accurately place QA marker 200 at the preset position or that the therapeutic radiation source 105 was did not achieve its preset position.
  • a rotational misalignment may add distortions or warping to the various components of exposure image 500 B. Accordingly, the presence of distortions, warping, or skewing of the target shadows or beam exposure field 510 is a further indicator that radiation treatment delivery system 100 is misaligned and therefore should be recalibrated prior to treating a patient.
  • spherical targets 215 or 405 may be elongated, star shape, cross-shaped, T-shaped, X-shaped, or otherwise.
  • a simple symmetrical shape alone such as a sphere, simplifies computation of the centroid of its shadow, but may only provide displacement error detection.
  • ring targets 410 enable detection of both displacement and rotational errors with minimal increase in difficulty of centroid computation.
  • a single more complicated shape may be used for both displacement and rotational error detection; however, the difficulty of computing the centroid of its shadow may correspondingly increase.
  • FIG. 6 is a flow chart illustrating a process 600 to provide quality assurance of alignment between the imaging guidance system, the positioning system, and therapeutic radiation source 105 of radiation treatment delivery system 100 , in accordance with an embodiment of the invention.
  • the order in which some or all of the process blocks appear in process 600 should not be deemed limiting. Rather, one of ordinary skill in the art having the benefit of the present disclosure will understand that some of the process blocks may be executed in a variety of orders not illustrated.
  • QA marker 130 is scanned using diagnostic imaging equipment to generate a reference image(s) of QA marker 130 .
  • a different imaging modality e.g., CT scan, MRI, PET, ultrasound, x-ray, microwave, etc.
  • a low density diagnostic alignment target 135 made of a material compatible with the diagnostic modality (e.g., acrylic for CT scans) may be inserted into QA marker 130 .
  • a treatment plan is generated based on the reference images.
  • the treatment plan may include a determination of the preset positions and orientations for QA marker 130 and therapeutic radiation source 105 , as wells as the dose to be delivered at each preset position during the alignment test.
  • an operator of radiation treatment delivery system 100 places QA marker 130 onto treatment couch 110 .
  • the low density diagnostic alignment target 135 may be swapped for the high density test alignment target 135 being made of a material compatible with therapeutic radiation source 105 (e.g., radio opaque material such as metal).
  • the reference image(s) are loaded into a control system of radiation treatment delivery system 100 .
  • the reference images are registered to the real-time images captured by detectors 115 and imaging sources 120 (the imaging guidance system).
  • the imaging guidance system registers fiducials 140 from each of the two images.
  • the positioning system translates/rotates treatment couch 110 to position QA marker 130 into the preset position within the field of view or operating range of therapeutic radiation source 105 to be used during the alignment test.
  • the positioning system places QA marker 130 into the preset position under the control of the imaging guidance system.
  • the alignment target 135 itself is used to track and place QA marker 130 , without fiducials 140 .
  • therapeutic radiation source 105 moves to its first preset position and delivers a dose of radiation beam 150 through QA marker 130 onto detector 115 A (or film positioned behind QA marker 130 ). Alignment target 135 casts a shadow onto detector 115 A creating an exposure image of itself and radiation beam 150 .
  • therapeutic radiation source 105 moves to its second preset position and delivers a second dose of radiation beam 150 through QA marker 130 onto detector 115 B (or film positioned behind QA marker 130 ).
  • Alignment target 135 casts a shadow onto detector 115 B creating another exposure image of itself and radiation beam 150 .
  • the two exposure images are imported into a computer and analyzed.
  • the film is first developed and then scanned into the computer for analysis.
  • a software tool e.g., RIT113 from Radiological Imaging technology, Inc.
  • the first exposure image may be uploaded directly into the analysis software once captured. If the analysis software determines that the centroids are not aligned, then the alignment test finishes without need of executing process block 630 , since it will already be determined that radiation treatment delivery system 100 is misaligned. Furthermore, embodiments of the invention are not limited only to a determination whether target shadows and the beam exposure field are concentrically aligned. Rather, embodiments of the invention may include configurations where non-concentrically aligned shadow shapes indicate alignment. Further, embodiments of the invention are not limited to a determination of whether centroids are aligned. Rather, the analysis software may look for alignment between shadow boundaries or various other features to determine alignment.
  • the two exposure images may also be analyzed for the amount of exposure within the beam exposure fields to determine whether therapeutic radiation source 105 delivered the correct dose of radiation. Analyzing for correct dose delivery may include comparing the exposure images against reference images to determine the dose of radiation delivered. In this case, the two exposure images are analyzed for overall system calibration, including both alignment verification and dose verification.
  • FIG. 7 is a block diagram illustrating a therapeutic patient treatment system 4000 for generating diagnostic images, generating a treatment plan, and delivering the treatment plan to a patient, in which features of the present invention may be implemented.
  • systems 4000 may include a diagnostic imaging system 1000 , a treatment planning system 2000 and a radiation treatment delivery system 100 .
  • Diagnostic imaging system 1000 may be any system capable of producing medical diagnostic images of a volume of interest (“VOI”) in a patient that may be used for subsequent medical diagnosis, treatment planning and/or treatment delivery.
  • diagnostic imaging system 1000 may be a computed tomography (“CT”) system, a magnetic resonance imaging (“MRI”) system, a positron emission tomography (“PET”) system, an ultrasound system or the like.
  • CT computed tomography
  • MRI magnetic resonance imaging
  • PET positron emission tomography
  • ultrasound system or the like.
  • diagnostic imaging system 1000 may be discussed below at times in relation to a CT x-ray imaging modality. However, other imaging modalities such as those above may also be used.
  • Diagnostic imaging system 1000 includes an imaging source 1010 to generate an imaging beam (e.g., x-rays, ultrasonic waves, radio frequency waves, etc.) and an imaging detector 1020 to detect and receive the beam generated by imaging source 1010 , or a secondary beam or emission stimulated by the beam from the imaging source (e.g., in an MRI or PET scan).
  • diagnostic imaging system 1000 may include two or more diagnostic X-ray sources and two or more corresponding imaging detectors.
  • two x-ray sources may be disposed around a patient to be imaged, fixed at an angular separation from each other (e.g., 90 degrees, 45 degrees, etc.) and aimed through the patient toward (an) imaging detector(s) which may be diametrically opposed to the x-ray sources.
  • an imaging detector(s) which may be diametrically opposed to the x-ray sources.
  • a single large imaging detector, or multiple imaging detectors, can also be used that would be illuminated by each x-ray imaging source.
  • other numbers and configurations of imaging sources and imaging detectors may be used.
  • the imaging source 1010 and the imaging detector 1020 are coupled to a digital processing system 1030 to control the imaging operation and process image data.
  • Diagnostic imaging system 1000 includes a bus or other means 1035 for transferring data and commands among digital processing system 1030 , imaging source 1010 and imaging detector 1020 .
  • Digital processing system 1030 may include one or more general-purpose processors (e.g., a microprocessor), special purpose processor such as a digital signal processor (“DSP”) or other type of device such as a controller or field programmable gate array (“FPGA”).
  • DSP digital signal processor
  • FPGA field programmable gate array
  • Digital processing system 1030 may also include other components (not shown) such as memory, storage devices, network adapters and the like.
  • Digital processing system 1030 may be configured to generate digital diagnostic images in a standard format, such as the DICOM (Digital Imaging and Communications in Medicine) format, for example. In other embodiments, digital processing system 1030 may generate other standard or non-standard digital image formats. Digital processing system 1030 may transmit diagnostic image files (e.g., the aforementioned DICOM formatted files) to treatment planning system 2000 over a data link 1500 , which may be, for example, a direct link, a local area network (“LAN”) link or a wide area network (“WAN”) link such as the Internet. In addition, the information transferred between systems may either be pulled or pushed across the communication medium connecting the systems, such as in a remote diagnosis or treatment planning configuration. In remote diagnosis or treatment planning, a user may utilize embodiments of the present invention to diagnose or treatment plan despite the existence of a physical separation between the system user and the patient.
  • DICOM Digital Imaging and Communications in Medicine
  • Treatment planning system 2000 includes a processing device 2010 to receive and process image data.
  • Processing device 2010 may represent one or more general-purpose processors (e.g., a microprocessor), special purpose processor such as a DSP or other type of device such as a controller or FPGA.
  • Processing device 2010 may be configured to execute instructions for performing treatment planning operations discussed herein.
  • Treatment planning system 2000 may also include system memory 2020 that may include a random access memory (“RAM”), or other dynamic storage devices, coupled to processing device 2010 by bus 2055 , for storing information and instructions to be executed by processing device 2010 .
  • System memory 2020 also may. be used for storing temporary variables or other intermediate information during execution of instructions by processing device 2010 .
  • System memory 2020 may also include a read only memory (“ROM”) and/or other static storage device coupled to bus 2055 for storing static information and instructions for processing device 2010 .
  • ROM read only memory
  • Treatment planning system 2000 may also include storage device 2030 , representing one or more storage devices (e.g., a magnetic disk drive or optical disk drive) coupled to bus 2055 for storing information and instructions.
  • Storage device 2030 may be used for storing instructions for performing the treatment planning steps discussed herein.
  • Processing device 2010 may also be coupled to a display device 2040 , such as a cathode ray tube (“CRT”) or liquid crystal display (“LCD”), for displaying information (e.g., a 2D or 3D representation of the VOI) to the user.
  • a display device 2040 such as a cathode ray tube (“CRT”) or liquid crystal display (“LCD”)
  • An input device 2050 such as a keyboard, may be coupled to processing device 2010 for communicating information and/or command selections to processing device 2010 .
  • One or more other user input devices e.g., a mouse, a trackball or cursor direction keys
  • treatment planning system 2000 represents only one example of a treatment planning system, which may have many different configurations and architectures, which may include more components or fewer components than treatment planning system 2000 and which may be employed with the present invention. For example, some systems often have multiple buses, such as a peripheral bus, a dedicated cache bus, etc.
  • the treatment planning system 2000 may also include MIRIT (Medical Image Review and Import Tool) to support DICOM import (so images can be fused and targets delineated on different systems and then imported into the treatment planning system for planning and dose calculations), expanded image fusion capabilities that allow the user to treatment plan and view dose distributions on any one of various imaging modalities (e.g., MRI, CT, PET, etc.).
  • MIRIT Medical Image Review and Import Tool
  • DICOM import so images can be fused and targets delineated on different systems and then imported into the treatment planning system for planning and dose calculations
  • expanded image fusion capabilities that allow the user to treatment plan and view dose distributions on any one of various imaging modalities (e.g., MRI,
  • Treatment planning system 2000 may share its database (e.g., data stored in storage device 2030 ) with a treatment delivery system, such as radiation treatment delivery system 100 , so that it may not be necessary to export from the treatment planning system prior to treatment delivery.
  • Treatment planning system 2000 may be linked to radiation treatment delivery system 100 via a data link 2500 , which may be a direct link, a LAN link or a WAN link as discussed above with respect to data link 1500 .
  • data links 1500 and 2500 are implemented as LAN or WAN connections, any of diagnostic imaging system 1000 , treatment planning system 2000 and/or radiation treatment delivery system 100 may be in decentralized locations such that the systems may be physically remote from each other.
  • any of diagnostic imaging system 1000 , treatment planning system 2000 and/or radiation treatment delivery system 100 may be integrated with each other in one or more systems.
  • Radiation treatment delivery system 100 includes a therapeutic and/or surgical radiation source 105 to administer a prescribed radiation dose to a target volume in conformance with a treatment plan. Radiation treatment delivery system 100 may also include an imaging system 3020 (including imaging sources 120 and detectors 115 ) to capture inter-treatment images of a patient volume (including the target volume) for registration or correlation with the diagnostic images described above in order to position the patient with respect to the radiation source. Radiation treatment delivery system 100 may also include a digital processing system 3030 to control therapeutic radiation source 105 , imaging system 3020 , and a patient support device such as a treatment couch 110 .
  • Digital processing system 3030 may include one or more general-purpose processors (e.g., a microprocessor), special purpose processor such as a DSP or other type of device such as a controller or FPGA. Digital processing system 3030 may also include other components (not shown) such as memory, storage devices, network adapters and the like. Digital processing system 3030 may be coupled to therapeutic radiation source 105 , imaging system 3020 and treatment couch 110 by a bus 3045 or other type of control and communication interface.
  • general-purpose processors e.g., a microprocessor
  • special purpose processor such as a DSP or other type of device such as a controller or FPGA.
  • Digital processing system 3030 may also include other components (not shown) such as memory, storage devices, network adapters and the like.
  • Digital processing system 3030 may be coupled to therapeutic radiation source 105 , imaging system 3020 and treatment couch 110 by a bus 3045 or other type of control and communication interface.
  • FIG. 8 is a perspective view of a radiation treatment delivery system 100 , in accordance with an embodiment of the invention.
  • radiation treatment delivery system 100 may be an image-guided, robotic-based radiation treatment system (e.g., for performing radiosurgery) such as the CyberKnife® system developed by Accuray, Inc. of California.
  • therapeutic radiation source 105 may be a linear accelerator (“LINAC”) mounted on the end of a robotic source arm 3012 having multiple (e.g., 5 or more) degrees of freedom in order to position the LINAC to irradiate a pathological anatomy (target region or volume) with beams delivered from many angles in an operating volume (e.g., a sphere) around the patient.
  • LINAC linear accelerator
  • Treatment may involve beam paths with a single isocenter (point of convergence), multiple isocenters, or with a non-isocentric approach (i.e., the beams need only intersect with the pathological target volume and do not necessarily converge on a single point, or isocenter, within the target). Treatment can be delivered in either a single session (mono-fraction) or in a small number of sessions (hypo-fractionation) as determined during treatment planning.
  • radiation beams may be delivered according to the treatment plan without fixing the patient to a rigid, external frame to register the intra-operative position of the target volume with the position of the target volume during the pre-operative treatment planning phase.
  • Imaging system 3020 may be represented by imaging sources 120 A and 120 B and detectors (imagers) 115 A and 115 B in FIG. 8 .
  • imaging sources 120 A and 120 B are X-ray sources.
  • two imaging sources 120 A and 120 B may be nominally aligned to project imaging x-ray beams through a patient from two different angular positions (e.g., separated by 90 degrees, 45 degrees, etc.) and aimed through the patient on treatment couch 110 toward respective detectors 115 A and 115 B.
  • a single large imager can be used that would be illuminated by each x-ray imaging source.
  • other numbers and configurations of imaging sources and detectors may be used.
  • Digital processing system 3030 may implement algorithms to register images obtained from imaging system 3020 with pre-operative treatment planning images in order to align the patient on the treatment couch 110 within the radiation treatment delivery system 100 , and to precisely position the therapeutic radiation source 105 with respect to the target volume.
  • treatment couch 110 is coupled to a robotic couch arm 3013 having multiple (e.g., 5 or more) degrees of freedom.
  • Robotic couch arm 3013 may have five rotational degrees of freedom and one substantially vertical, linear degree of freedom.
  • robotic couch arm 3013 may have six rotational degrees of freedom and one substantially vertical, linear degree of freedom or at least four rotational degrees of freedom.
  • Robotic couch arm 3013 may be vertically mounted to a column or wall, or horizontally mounted to pedestal, floor, or ceiling.
  • the treatment couch 110 may be a component of another mechanical mechanism, such as the AxumTM treatment couch developed by Accuray, Inc. of California, or be another type of conventional treatment table known to those of ordinary skill in the art.
  • Robotic couch arm 3013 and treatment couch 110 may be referred to as a positioning system for a patient.
  • radiation treatment delivery system 100 may be another type of treatment delivery system, for example, a gantry based (isocentric) intensity modulated radiotherapy (“IMRT”) system.
  • IMRT intensity modulated radiotherapy
  • a therapeutic radiation source e.g., a LINAC
  • LINAC a therapeutic radiation source
  • Radiation is then delivered from several positions on the circular plane of rotation.
  • the shape of the radiation beam is defined by a multi-leaf collimator that allows portions of the beam to be blocked, so that the remaining beam incident on the patient has a pre-defined shape.
  • the resulting system generates arbitrarily shaped radiation beams that intersect each other at the isocenter to deliver a dose distribution to the target.
  • the optimization algorithm selects subsets of the main beam and determines the amount of time that the patient should be exposed to each subset, so that the prescribed dose constraints are best met.
  • the methods and apparatus described herein are not limited to use only with medical diagnostic imaging and treatment.
  • the methods and apparatus herein may be used in applications outside of the medical technology field, such as industrial imaging and non-destructive testing of materials (e.g., motor blocks in the automotive industry, airframes in the aviation industry, welds in the construction industry and drill cores in the petroleum industry) and seismic surveying.
  • treatment may refer generally to the application of radiation beam(s).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
US11/234,708 2005-09-23 2005-09-23 Integrated quality assurance for in image guided radiation treatment delivery system Expired - Lifetime US7356120B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US11/234,708 US7356120B2 (en) 2005-09-23 2005-09-23 Integrated quality assurance for in image guided radiation treatment delivery system
PCT/US2006/036620 WO2007038123A2 (fr) 2005-09-23 2006-09-20 Assurance qualité intégrée pour un système d’administration de traitement par radiation guidée par images
US12/070,106 US7604405B2 (en) 2005-09-23 2008-02-14 Integrated quality assurance for an image guided radiation treatment delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/234,708 US7356120B2 (en) 2005-09-23 2005-09-23 Integrated quality assurance for in image guided radiation treatment delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/070,106 Division US7604405B2 (en) 2005-09-23 2008-02-14 Integrated quality assurance for an image guided radiation treatment delivery system

Publications (2)

Publication Number Publication Date
US20070071176A1 US20070071176A1 (en) 2007-03-29
US7356120B2 true US7356120B2 (en) 2008-04-08

Family

ID=37893955

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/234,708 Expired - Lifetime US7356120B2 (en) 2005-09-23 2005-09-23 Integrated quality assurance for in image guided radiation treatment delivery system
US12/070,106 Expired - Lifetime US7604405B2 (en) 2005-09-23 2008-02-14 Integrated quality assurance for an image guided radiation treatment delivery system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/070,106 Expired - Lifetime US7604405B2 (en) 2005-09-23 2008-02-14 Integrated quality assurance for an image guided radiation treatment delivery system

Country Status (2)

Country Link
US (2) US7356120B2 (fr)
WO (1) WO2007038123A2 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050229251A1 (en) * 2004-03-31 2005-10-13 Chellapilla Kumar H High performance content alteration architecture and techniques
US20070170373A1 (en) * 2006-01-26 2007-07-26 Dieter Manthey Image-based flat panel alignment
US20080170671A1 (en) * 2007-01-03 2008-07-17 Xiaodong Wu Apparatus and method for robotic radiosurgery beam geometry quality assurance
US20080240364A1 (en) * 2007-03-29 2008-10-02 Main William T Phantom insert for quality assurance
US7531810B2 (en) * 2005-08-04 2009-05-12 James G. Schwade Integrated half-beam profile measurement and polar profile for circular radiation field symmetry assessment
US20090213995A1 (en) * 2008-03-14 2009-08-27 Levine Zachary H Dimensional reference for tomography
US20090238338A1 (en) * 2006-02-28 2009-09-24 Elekta Ab (Publ) Radiotherapeutic apparatus
WO2011091069A1 (fr) * 2010-01-19 2011-07-28 Ardian, Inc. Procédés et appareil pour la neuromodulation rénale par radiothérapie stéréotaxique
US20180098745A1 (en) * 2015-04-24 2018-04-12 Ion Beam Applications S.A. Phantom and method for quality assurance of a particle therapy apparatus
US20190060674A1 (en) * 2017-08-29 2019-02-28 Sensus Healthcare, Inc. Robotic iort x-ray radiation system with calibration well
US10607802B2 (en) 2017-03-31 2020-03-31 Sensus Healthcare, Inc. Three-dimensional beam forming X-ray source
US10646726B2 (en) 2016-07-13 2020-05-12 Sensus Healthcare, Inc. Robotic intraoperative radiation therapy
US10940334B2 (en) 2018-10-19 2021-03-09 Sensus Healthcare, Inc. Systems and methods for real time beam sculpting intra-operative-radiation-therapy treatment planning
US11045667B2 (en) 2017-07-18 2021-06-29 Sensus Healthcare, Inc. Real-time x-ray dosimetry in intraoperative radiation therapy
US20210290981A1 (en) * 2018-07-12 2021-09-23 Our United Corporation Method and system for checking consistency between radiotherapy equipment isocenter and treatment isocenter
US11672491B2 (en) 2018-03-30 2023-06-13 Empyrean Medical Systems, Inc. Validation of therapeutic radiation treatment

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8075183B2 (en) * 2005-06-17 2011-12-13 Volumetrics Medical Corp. Method of evaluating the resolution of a volumetric imaging system and image phantom used during the resolution evaluation
US7656998B2 (en) * 2005-11-14 2010-02-02 Accuray Incorporated Unified quality assurance for a radiation treatment delivery system
US7402819B2 (en) 2005-12-01 2008-07-22 Accuray Incorporated Respiration phantom for quality assurance
US7620147B2 (en) * 2006-12-13 2009-11-17 Oraya Therapeutics, Inc. Orthovoltage radiotherapy
US7535991B2 (en) * 2006-10-16 2009-05-19 Oraya Therapeutics, Inc. Portable orthovoltage radiotherapy
US8363783B2 (en) 2007-06-04 2013-01-29 Oraya Therapeutics, Inc. Method and device for ocular alignment and coupling of ocular structures
US8920406B2 (en) * 2008-01-11 2014-12-30 Oraya Therapeutics, Inc. Device and assembly for positioning and stabilizing an eye
JP5250251B2 (ja) * 2007-12-17 2013-07-31 イマグノーシス株式会社 医用撮影用マーカーおよびその活用プログラム
US7801271B2 (en) 2007-12-23 2010-09-21 Oraya Therapeutics, Inc. Methods and devices for orthovoltage ocular radiotherapy and treatment planning
WO2009085204A2 (fr) 2007-12-23 2009-07-09 Oraya Therapeutics, Inc. Procédés et dispositifs permettant de détecter, contrôler et prévoir l'administration d'un rayonnement
US8086004B2 (en) * 2008-01-15 2011-12-27 Accuray Incorporated Use of a single X-ray image for quality assurance of tracking
US8792614B2 (en) 2009-03-31 2014-07-29 Matthew R. Witten System and method for radiation therapy treatment planning using a memetic optimization algorithm
FR2945955B1 (fr) * 2009-06-02 2012-03-23 Qualiformed Sarl Objet-test pour le controle qualite d'un appareil de traitement par radiotherapie et procedes de fabrication et d'utilisation dudit objet-test.
EP2490593B1 (fr) * 2009-10-22 2019-11-06 Koninklijke Philips N.V. Appareil d'évaluation de protocole d'acquisition
US8824630B2 (en) * 2010-10-29 2014-09-02 Accuray Incorporated Method and apparatus for treating a target's partial motion range
US8849633B2 (en) 2010-10-29 2014-09-30 Accuray Incorporated Method and apparatus for selecting a tracking method to use in image guided treatment
AR095182A1 (es) 2012-05-07 2015-09-30 Omthera Pharmaceuticals Inc Composiciones de estatinas y ácidos grasos omega-3
US9241679B2 (en) * 2012-06-26 2016-01-26 Siemens Aktiengesellschaft Method and apparatus for filtering high-frequency electromagnetic beams and irradiation apparatus or device for irradiating an object
US8845191B2 (en) * 2012-07-13 2014-09-30 The Chinese University Of Hong Kong Compound 6D-offset simulating phantom and quality assurance program for precision image-guided radiotherapy and radiosurgery
US20140078863A1 (en) * 2012-09-17 2014-03-20 Elwha Llc Assaying gold with a microwave pulse
CN102908160A (zh) * 2012-11-20 2013-02-06 新疆医科大学附属肿瘤医院 图像引导放疗质量保证模体
US9649080B2 (en) * 2012-12-05 2017-05-16 Samsung Electronics Co., Ltd. X-ray imaging apparatus and method for controlling the same
CN104414662B (zh) * 2013-09-04 2017-02-01 江苏瑞尔医疗科技有限公司 成像设备的位置校准和误差补偿装置及其补偿方法
US20160256714A1 (en) * 2013-10-01 2016-09-08 Empire Technology Development Llc Visualization of beam trajectories in radiation therapy
EP3195901A1 (fr) * 2016-01-20 2017-07-26 Ion Beam Applications S.A. Procede et dispositif pour determiner un interet d'appliquer une procedure qa sur un plan de traitement en radiotherapie
US12128252B2 (en) 2017-01-06 2024-10-29 Accuray Incorporated No-view interfraction treatment target motion management using volumetric imaging
WO2019040056A1 (fr) * 2017-08-23 2019-02-28 Carestream Dental Technology Topco Limited Système de tomosynthèse du côté d'un fauteuil dentaire
US11291865B2 (en) * 2017-11-07 2022-04-05 Standard Imaging, Inc. Verification system for robotic radiosurgery
GB201802597D0 (en) * 2018-02-16 2018-04-04 Vision Rt Ltd A calibration object for calibrating a patient monitoring system
WO2020146088A1 (fr) * 2019-01-07 2020-07-16 University Of Kentucky Research Foundation Dispositif d'assurance qualité doté d'un composant optique passif et d'une caméra à distance
US11282202B2 (en) * 2019-03-08 2022-03-22 William E. Butler Temporal calibration of an angiographic imaging system
CN112169187B (zh) * 2019-07-02 2025-07-08 西安大医集团股份有限公司 一种仿真模体
GB2603764B (en) * 2021-02-10 2023-05-17 Elekta ltd Detection device for determining a position of a phantom
US12427343B2 (en) * 2021-03-24 2025-09-30 University Of Kentucky Research Foundation Cradle and feedback mechanism for automated device alignment in radiation therapy
CN113491844B (zh) 2021-07-30 2022-04-29 北京瑞尔世维医学研究有限公司 一种全球面放射治疗系统
CN115501506B (zh) * 2022-11-09 2023-03-24 合肥中科离子医学技术装备有限公司 粒子放射治疗系统及粒子放射治疗系统的控制方法
US12285632B2 (en) * 2023-04-13 2025-04-29 Aaron Anthony Kempenich Fixed-point mammalian spine-like apparatus that provides an accurate and fixed alignment point of reference for pre-treatment CT while phantom and radiation detectors of a dynamic radiation oncological phantom system are in motion and a tumor tracking block with a target object of variable size, shape, and density and metal fiducial markers used to mark tumors in human treatment
CN120022009A (zh) * 2024-06-03 2025-05-23 北京睿华辰医疗科技有限公司 多机器人图像引导放疗系统及其成像方法

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1252550A (en) 1914-12-15 1918-01-08 Ralph P Champney Driving apparatus.
US5193106A (en) * 1990-08-28 1993-03-09 Desena Danforth X-ray identification marker
US6267502B1 (en) * 1998-04-10 2001-07-31 Minrad Inc. Alignment verification device and method of using the same with a visual light beam and an x-ray
US20020085668A1 (en) * 2000-10-17 2002-07-04 Andreas Blumhofer Method and device for accurately positioning a patient in radiotherapy and/or radiosurgery
US6516046B1 (en) * 1999-11-04 2003-02-04 Brainlab Ag Exact patient positioning by compairing reconstructed x-ray images and linac x-ray images
US6529575B1 (en) * 2002-04-29 2003-03-04 Ge Medical Systems Global Technology Company, Llc Adaptive projection filtering scheme for noise reduction
US6528803B1 (en) 2000-01-21 2003-03-04 Radiological Imaging Technology, Inc. Automated calibration adjustment for film dosimetry
US6675116B1 (en) 2000-09-22 2004-01-06 Radiological Imaging Technology, Inc. Automated calibration for radiation dosimetry using fixed or moving beams and detectors
US20040042583A1 (en) * 2002-07-12 2004-03-04 Andreas Wackerle Patient positioning system for radiotherapy/radiosurgery based on stereoscopic X-ray unit
FR2854050A1 (fr) * 2003-04-23 2004-10-29 Assist Publ Hopitaux De Paris Fantome pour le controle qualite d'un systeme de simulation virtuelle d'un traitement de radiotherapie
US20050080332A1 (en) * 2003-10-10 2005-04-14 Shiu Almon S. Near simultaneous computed tomography image-guided stereotactic radiotherapy
US7056019B1 (en) * 2002-10-22 2006-06-06 Todd Hanson Quality assurance phantom system
US7197830B2 (en) * 2005-03-18 2007-04-03 The Boeing Company Alignment quality indicator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831269B2 (en) * 2002-10-22 2004-12-14 Iso-Science Laboratories, Inc. Lesion phantoms with no inner cold encapsulation
US6927406B2 (en) * 2002-10-22 2005-08-09 Iso-Science Laboratories, Inc. Multimodal imaging sources

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1252550A (en) 1914-12-15 1918-01-08 Ralph P Champney Driving apparatus.
US5193106A (en) * 1990-08-28 1993-03-09 Desena Danforth X-ray identification marker
US6267502B1 (en) * 1998-04-10 2001-07-31 Minrad Inc. Alignment verification device and method of using the same with a visual light beam and an x-ray
US6516046B1 (en) * 1999-11-04 2003-02-04 Brainlab Ag Exact patient positioning by compairing reconstructed x-ray images and linac x-ray images
US6528803B1 (en) 2000-01-21 2003-03-04 Radiological Imaging Technology, Inc. Automated calibration adjustment for film dosimetry
US6675116B1 (en) 2000-09-22 2004-01-06 Radiological Imaging Technology, Inc. Automated calibration for radiation dosimetry using fixed or moving beams and detectors
US20020085668A1 (en) * 2000-10-17 2002-07-04 Andreas Blumhofer Method and device for accurately positioning a patient in radiotherapy and/or radiosurgery
US6529575B1 (en) * 2002-04-29 2003-03-04 Ge Medical Systems Global Technology Company, Llc Adaptive projection filtering scheme for noise reduction
US20040042583A1 (en) * 2002-07-12 2004-03-04 Andreas Wackerle Patient positioning system for radiotherapy/radiosurgery based on stereoscopic X-ray unit
US7056019B1 (en) * 2002-10-22 2006-06-06 Todd Hanson Quality assurance phantom system
FR2854050A1 (fr) * 2003-04-23 2004-10-29 Assist Publ Hopitaux De Paris Fantome pour le controle qualite d'un systeme de simulation virtuelle d'un traitement de radiotherapie
US20060239414A1 (en) * 2003-04-23 2006-10-26 Jean-Noel Foulquier Phantom which is intended for the quality control of a virtual radiotherapy treatment simulation system
US20050080332A1 (en) * 2003-10-10 2005-04-14 Shiu Almon S. Near simultaneous computed tomography image-guided stereotactic radiotherapy
US7197830B2 (en) * 2005-03-18 2007-04-03 The Boeing Company Alignment quality indicator

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Anthropomorphic Phantoms," Radiological Physics Center. Retrieved from http://rpc.mdanderson.org/rpc/services/Anthropomorphic<SUB>-</SUB>%20Phantoms/Anth<SUB>-</SUB>SRS.htm (Retrieved on Mar. 28, 2007).
"Dynamic Phantom," CIRS Model 008 Dynamic Thorax Phantom Specifications, pp. 53-54.
"Instructions for SRS Quality Audit System," Radiological Physics Center. Retrieved from http://rpc.mdanderson.org/rpc/services/Anthropomorphic<SUB>-</SUB>%20Phantoms/SRSInstrucForInst.pdf (Retrieved on Mar. 28, 2007).
Low et al., Minimization of target positioning error in accelerator-based radiosurgery, Medical Physics, 22, (4), pp. 443-448, Apr. 1995. *
PCT/US06/36620, International Search Report (United States), dated Jun. 7, 2007.
PCT/US06/36620, Written Opinion of the International Searching Authority (United States), dated May 14, 2007.
Yu, Cheng Ph.D. et al., "An Anthropomorphic Phantom Study of the Accuracy of CyberKnife Spinal Radiosurgery," NEUROSURGERY, vol. 55, No. 5, Nov. 2004, pp. 1138-1149.

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050229251A1 (en) * 2004-03-31 2005-10-13 Chellapilla Kumar H High performance content alteration architecture and techniques
US7505946B2 (en) * 2004-03-31 2009-03-17 Microsoft Corporation High performance content alteration architecture and techniques
US7531810B2 (en) * 2005-08-04 2009-05-12 James G. Schwade Integrated half-beam profile measurement and polar profile for circular radiation field symmetry assessment
US20070170373A1 (en) * 2006-01-26 2007-07-26 Dieter Manthey Image-based flat panel alignment
US7511286B2 (en) * 2006-01-26 2009-03-31 Siemens Medical Solutions Usa, Inc. Image-based flat panel alignment
US7907699B2 (en) * 2006-02-28 2011-03-15 Elekta Ab (Publ) Radiotherapeutic apparatus
US20090238338A1 (en) * 2006-02-28 2009-09-24 Elekta Ab (Publ) Radiotherapeutic apparatus
US7780349B2 (en) * 2007-01-03 2010-08-24 James G. Schwade Apparatus and method for robotic radiosurgery beam geometry quality assurance
US20080170671A1 (en) * 2007-01-03 2008-07-17 Xiaodong Wu Apparatus and method for robotic radiosurgery beam geometry quality assurance
US20080240364A1 (en) * 2007-03-29 2008-10-02 Main William T Phantom insert for quality assurance
US7594753B2 (en) 2007-03-29 2009-09-29 Accuray Incorporated Phantom insert for quality assurance
US20090213995A1 (en) * 2008-03-14 2009-08-27 Levine Zachary H Dimensional reference for tomography
US7967507B2 (en) * 2008-03-14 2011-06-28 The United States of America as represented by the Secretary of Commerce, NIST Dimensional reference for tomography
US20110200171A1 (en) * 2010-01-19 2011-08-18 Ardian, Inc. Methods and apparatus for renal neuromodulation via stereotactic radiotherapy
WO2011091069A1 (fr) * 2010-01-19 2011-07-28 Ardian, Inc. Procédés et appareil pour la neuromodulation rénale par radiothérapie stéréotaxique
US20180098745A1 (en) * 2015-04-24 2018-04-12 Ion Beam Applications S.A. Phantom and method for quality assurance of a particle therapy apparatus
US10105119B2 (en) * 2015-04-24 2018-10-23 Ion Beam Applications S.A. Phantom and method for quality assurance of a particle therapy apparatus
US10646726B2 (en) 2016-07-13 2020-05-12 Sensus Healthcare, Inc. Robotic intraoperative radiation therapy
US11521820B2 (en) 2017-03-31 2022-12-06 Empyrean Medical Systems, Inc. Three-dimensional beam forming x-ray source
US12340968B2 (en) 2017-03-31 2025-06-24 Empyrean Medical Systems, Inc. Three-dimensional beam forming X-ray source
US10607802B2 (en) 2017-03-31 2020-03-31 Sensus Healthcare, Inc. Three-dimensional beam forming X-ray source
US12027341B2 (en) 2017-03-31 2024-07-02 Empyrean Medical Systems, Inc. Three-dimensional beam forming X-ray source
US11045667B2 (en) 2017-07-18 2021-06-29 Sensus Healthcare, Inc. Real-time x-ray dosimetry in intraoperative radiation therapy
US20190060674A1 (en) * 2017-08-29 2019-02-28 Sensus Healthcare, Inc. Robotic iort x-ray radiation system with calibration well
US10350437B2 (en) * 2017-08-29 2019-07-16 Sensus Healthcare, Inc. Robotic IORT x-ray radiation system with calibration well
US11672491B2 (en) 2018-03-30 2023-06-13 Empyrean Medical Systems, Inc. Validation of therapeutic radiation treatment
US20210290981A1 (en) * 2018-07-12 2021-09-23 Our United Corporation Method and system for checking consistency between radiotherapy equipment isocenter and treatment isocenter
US12138484B2 (en) * 2018-07-12 2024-11-12 Our United Corporation Method and system for checking consistency between radiotherapy equipment isocenter and treatment isocenter
US10940334B2 (en) 2018-10-19 2021-03-09 Sensus Healthcare, Inc. Systems and methods for real time beam sculpting intra-operative-radiation-therapy treatment planning

Also Published As

Publication number Publication date
US20080144776A1 (en) 2008-06-19
WO2007038123A2 (fr) 2007-04-05
WO2007038123A3 (fr) 2007-08-16
US20070071176A1 (en) 2007-03-29
US7604405B2 (en) 2009-10-20

Similar Documents

Publication Publication Date Title
US7356120B2 (en) Integrated quality assurance for in image guided radiation treatment delivery system
US7656998B2 (en) Unified quality assurance for a radiation treatment delivery system
US7594753B2 (en) Phantom insert for quality assurance
US8406851B2 (en) Patient tracking using a virtual image
US7620144B2 (en) Parallel stereovision geometry in image-guided radiosurgery
US7402819B2 (en) Respiration phantom for quality assurance
US7477722B2 (en) Imaging geometry for image-guided radiosurgery
US8417318B2 (en) Calibrating tracking systems to remove position-dependent bias
US8831706B2 (en) Fiducial-less tracking of a volume of interest
US7623623B2 (en) Non-collocated imaging and treatment in image-guided radiation treatment systems
CN101952837B (zh) 用于跟踪的质量保证的立体成像对中的单个x射线图像的使用
US10702712B2 (en) Tumor tracking during radiation treatment using ultrasound imaging
CN103229178B (zh) 用于治疗靶的部分活动范围的方法和仪器
CN1672651B (zh) 在有呼吸运动的情况下用于放射治疗的患者定位系统和方法
US12144671B2 (en) Universal phantom for calibration and verification of optical and radiation systems

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACCURAY INCORPORATED, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAIN, WILLIAM;EARNST, ERIC;KUDUVALLI, GOPINATH;REEL/FRAME:017029/0169

Effective date: 20050923

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT, NEW YORK

Free format text: ASSIGNMENT FOR SECURITY - PATENTS;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:037513/0170

Effective date: 20160111

Owner name: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGEN

Free format text: ASSIGNMENT FOR SECURITY - PATENTS;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:037513/0170

Effective date: 20160111

AS Assignment

Owner name: MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST), MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:042826/0358

Effective date: 20170614

Owner name: ACCURAY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CERBERUS BUSINESS FINANCE, LLC. AS COLLATERAL AGENT;REEL/FRAME:042821/0580

Effective date: 20170614

Owner name: TOMOTHERAPY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CERBERUS BUSINESS FINANCE, LLC. AS COLLATERAL AGENT;REEL/FRAME:042821/0580

Effective date: 20170614

Owner name: MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMEN

Free format text: SECURITY INTEREST;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:042826/0358

Effective date: 20170614

AS Assignment

Owner name: MIDCAP FINANCIAL TRUST, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:044910/0685

Effective date: 20171215

AS Assignment

Owner name: MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO EXISTING

Free format text: ASSIGNMENT OF SECURITY AGREEMENTS;ASSIGNOR:MIDCAP FUNDING X TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST), AS EXISTING ADMINISTRATIVE AGENT;REEL/FRAME:048481/0804

Effective date: 20190221

Owner name: MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO EXISTING ADMINISTRATIVE AGENT, MARYLAND

Free format text: ASSIGNMENT OF SECURITY AGREEMENTS;ASSIGNOR:MIDCAP FUNDING X TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST), AS EXISTING ADMINISTRATIVE AGENT;REEL/FRAME:048481/0804

Effective date: 20190221

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12

AS Assignment

Owner name: SILICON VALLEY BANK, AS ADMINISTRATIVE AND COLLATERAL AGENT, CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNORS:ACCURAY INCORPORATED;TOMOTHERAPY INCORPORATED;REEL/FRAME:056247/0001

Effective date: 20210514

AS Assignment

Owner name: ACCURAY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING X TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST);REEL/FRAME:056318/0559

Effective date: 20210514

Owner name: TOMOTHERAPY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FUNDING IV TRUST (AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING X TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FUNDING IV TRUST, AS SUCCESSOR BY ASSIGNMENT FROM MIDCAP FINANCIAL TRUST);REEL/FRAME:056318/0559

Effective date: 20210514

Owner name: ACCURAY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:056318/0751

Effective date: 20210514

Owner name: TOMOTHERAPY INCORPORATED, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:056318/0751

Effective date: 20210514

AS Assignment

Owner name: ACCURAY INCORPORATED, WISCONSIN

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:FIRST-CITIZENS BANK & TRUST COMPANY;REEL/FRAME:071638/0034

Effective date: 20250606

AS Assignment

Owner name: ACCURAY LLC, WISCONSIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACCURAY INCORPORATED;REEL/FRAME:072421/0584

Effective date: 20250805